Page last updated: 2024-11-03

probenecid and Demyelinating Diseases

probenecid has been researched along with Demyelinating Diseases in 2 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.

Research Excerpts

ExcerptRelevanceReference
"Probenecid is a pannexin-1 antagonist and a probenecid therapy was investigated."1.46Probenecid-treatment reduces demyelination induced by cuprizone feeding. ( Becker, P; Beisswenger, C; Hainz, N; Meier, C; Rapp, D; Tschernig, T; Wagenpfeil, S; Wonnenberg, B, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hainz, N1
Becker, P1
Rapp, D1
Wagenpfeil, S1
Wonnenberg, B1
Beisswenger, C1
Tschernig, T1
Meier, C1
Sonninen, V1
Riekkinen, P1
Rinne, UK1

Other Studies

2 other studies available for probenecid and Demyelinating Diseases

ArticleYear
Probenecid-treatment reduces demyelination induced by cuprizone feeding.
    Journal of chemical neuroanatomy, 2017, Volume: 85

    Topics: Animals; Cuprizone; Demyelinating Diseases; Diet; Disease Models, Animal; Leukocytes; Lymphocytes; M

2017
Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
    Neurology, 1973, Volume: 23, Issue:7

    Topics: Acute Disease; Adult; Brain; Chronic Disease; Demyelinating Diseases; Female; Homovanillic Acid; Hum

1973